Paper · 11368285
References127
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
1 to 20 of 127
Download this page as JSON| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 2 | 890,666 | A clinical staging system for chronic lymphocytic leukemia: prognostic significance. | Cancer | 1977 | https://conductscience.org/library/papers/890666 | PubMed |
| 3 | 2,784,491 | Pentostatin in chronic lymphocytic leukemia: a phase II trial of Cancer and Leukemia group B. | J Clin Oncol | 1989 | https://conductscience.org/library/papers/2784491 | PubMed |
| 4 | 5,953,036 | X-radiation and alkylating agents as possible "trigger" mechanisms in the autoimmune complications of malignant lymphophroliferative disease. | Clin Exp Immunol | 1966 | https://conductscience.org/library/papers/5953036 | PubMed |
| 5 | 10,334,546 | Pharmacokinetic study of single doses of oral fludarabine phosphate in patients with "low-grade" non-Hodgkin's lymphoma and B-cell chronic lymphocytic leukemia. | J Clin Oncol | 1999 | https://conductscience.org/library/papers/10334546 | PubMed |
| 6 | 9,885,918 | Immunologic self-tolerance maintained by CD25+CD4+ naturally anergic and suppressive T cells: induction of autoimmune disease by breaking their anergic/suppressive state. | Int Immunol | 1998 | https://conductscience.org/library/papers/9885918 | PubMed |
| 7 | 10,319,383 | Splenic lymphoma with circulating villous lymphocytes/splenic marginal-zone lymphoma. | Semin Hematol | 1999 | https://conductscience.org/library/papers/10319383 | PubMed |
| 8 | 8,943,862 | Prognostic importance of serum soluble CD23 level in chronic lymphocytic leukemia. | Blood | 1996 | https://conductscience.org/library/papers/8943862 | PubMed |
| 9 | 8,102,691 | Pure red-cell aplasia with fludarabine for chronic lymphocytic leukaemia. | Lancet | 1993 | https://conductscience.org/library/papers/8102691 | PubMed |
| 10 | 7,612,497 | Fatal recurrence of autoimmune hemolytic anemia following pentostatin therapy in a patient with a history of fludarabine-associated hemolytic anemia. | Ann Oncol | 1995 | https://conductscience.org/library/papers/7612497 | PubMed |
| 11 | 9,698,219 | Severe autoimmune hemolytic anemia in eight patients treated with fludarabine. | Hematol Cell Ther | 1998 | https://conductscience.org/library/papers/9698219 | PubMed |
| 12 | 10,355,587 | Acute myeloid leukemia and myelodysplasia in patients with chronic lymphocytic leukemia receiving fludarabine as initial therapy. | Ann Oncol | 1999 | https://conductscience.org/library/papers/10355587 | PubMed |
| 13 | 27,463,495 | 2-Chlorodeoxyadenosine Treatment of Refractory Chronic Lymphocytic Leukemia. | Leuk Lymphoma | 1991 | https://conductscience.org/library/papers/27463495 | PubMed |
| 14 | 8,641,639 | Prophylaxis against infections with low-dose intravenous immunoglobulins (IVIG) in chronic lymphocytic leukemia. Results of a crossover study. | Haematologica | 1996 | https://conductscience.org/library/papers/8641639 | PubMed |
| 15 | 10,477,712 | Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia. | Blood | 1999 | https://conductscience.org/library/papers/10477712 | PubMed |
| 16 | 8,547,072 | Fludarabine-related autoimmune haemolytic anaemia in patients with chronic lymphocytic leukaemia. | Br J Haematol | 1995 | https://conductscience.org/library/papers/8547072 | PubMed |
| 17 | 9,670,041 | CD4+CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. | J Exp Med | 1998 | https://conductscience.org/library/papers/9670041 | PubMed |
| 18 | 9,593,789 | Chlorambucil in indolent chronic lymphocytic leukemia. French Cooperative Group on Chronic Lymphocytic Leukemia. | N Engl J Med | 1998 | https://conductscience.org/library/papers/9593789 | PubMed |
| 19 | 4,693,581 | Chlorambucil vs. combined chlorambucil-corticosteroid therapy in chronic lymphocytic leukemia. | Cancer | 1973 | https://conductscience.org/library/papers/4693581 | PubMed |
| 20 | 7,669,706 | Purine analogs in the treatment of low-grade lymphomas and chronic lymphocytic leukemias. | Ann Oncol | 1995 | https://conductscience.org/library/papers/7669706 | PubMed |
| 21 | 9,482,528 | Old and new therapies in chronic lymphocytic leukemia: now is the time for a reassessment of therapeutic goals. | Semin Oncol | 1998 | https://conductscience.org/library/papers/9482528 | PubMed |
papers-2026-11-12-0.1.0
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/papers/v1/11368285/references